CN106036314A - Oral liquid containing gamma-aminobutyric acid - Google Patents
Oral liquid containing gamma-aminobutyric acid Download PDFInfo
- Publication number
- CN106036314A CN106036314A CN201610391411.7A CN201610391411A CN106036314A CN 106036314 A CN106036314 A CN 106036314A CN 201610391411 A CN201610391411 A CN 201610391411A CN 106036314 A CN106036314 A CN 106036314A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- aminobutyric acid
- gamma
- acid
- ganoderma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 title claims abstract description 83
- 229960003692 gamma aminobutyric acid Drugs 0.000 title claims abstract description 44
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 title claims abstract description 37
- 239000007788 liquid Substances 0.000 title claims abstract description 19
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 36
- 239000000843 powder Substances 0.000 claims abstract description 29
- 239000011782 vitamin Substances 0.000 claims abstract description 19
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims abstract description 16
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000010931 gold Substances 0.000 claims abstract description 16
- 229910052737 gold Inorganic materials 0.000 claims abstract description 16
- 229940088594 vitamin Drugs 0.000 claims abstract description 16
- 229930003231 vitamin Natural products 0.000 claims abstract description 16
- 235000013343 vitamin Nutrition 0.000 claims abstract description 16
- 235000021433 fructose syrup Nutrition 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000004471 Glycine Substances 0.000 claims abstract description 8
- 239000012153 distilled water Substances 0.000 claims abstract description 8
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 5
- 241000222336 Ganoderma Species 0.000 claims description 25
- 241000208340 Araliaceae Species 0.000 claims description 20
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 20
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 20
- 235000008434 ginseng Nutrition 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 15
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 15
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- 229930091371 Fructose Natural products 0.000 claims description 8
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 8
- 239000005715 Fructose Substances 0.000 claims description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 7
- 102000008214 Glutamate decarboxylase Human genes 0.000 claims description 7
- 108091022930 Glutamate decarboxylase Proteins 0.000 claims description 7
- 238000001802 infusion Methods 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 4
- 235000005979 Citrus limon Nutrition 0.000 claims description 4
- 244000131522 Citrus pyriformis Species 0.000 claims description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 4
- 229930003270 Vitamin B Natural products 0.000 claims description 4
- 229930003268 Vitamin C Natural products 0.000 claims description 4
- 229930003316 Vitamin D Natural products 0.000 claims description 4
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 4
- 229930003427 Vitamin E Natural products 0.000 claims description 4
- 229930003448 Vitamin K Natural products 0.000 claims description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 4
- 230000003197 catalytic effect Effects 0.000 claims description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 235000013922 glutamic acid Nutrition 0.000 claims description 4
- 239000004220 glutamic acid Substances 0.000 claims description 4
- 239000004310 lactic acid Substances 0.000 claims description 4
- 235000014655 lactic acid Nutrition 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 235000019155 vitamin A Nutrition 0.000 claims description 4
- 239000011719 vitamin A Substances 0.000 claims description 4
- 235000019156 vitamin B Nutrition 0.000 claims description 4
- 239000011720 vitamin B Substances 0.000 claims description 4
- 235000019154 vitamin C Nutrition 0.000 claims description 4
- 239000011718 vitamin C Substances 0.000 claims description 4
- 235000019166 vitamin D Nutrition 0.000 claims description 4
- 239000011710 vitamin D Substances 0.000 claims description 4
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 4
- 235000019165 vitamin E Nutrition 0.000 claims description 4
- 229940046009 vitamin E Drugs 0.000 claims description 4
- 239000011709 vitamin E Substances 0.000 claims description 4
- 235000019168 vitamin K Nutrition 0.000 claims description 4
- 239000011712 vitamin K Substances 0.000 claims description 4
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 4
- 229940045997 vitamin a Drugs 0.000 claims description 4
- 229940046008 vitamin d Drugs 0.000 claims description 4
- 229940046010 vitamin k Drugs 0.000 claims description 4
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 claims description 3
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 claims description 3
- 241000207199 Citrus Species 0.000 claims description 3
- 241000446313 Lamella Species 0.000 claims description 3
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 3
- YDBYJHTYSHBBAU-YFKPBYRVSA-N S-methyl-L-methioninate Chemical compound C[S+](C)CC[C@H](N)C([O-])=O YDBYJHTYSHBBAU-YFKPBYRVSA-N 0.000 claims description 3
- 108010084210 citrin Proteins 0.000 claims description 3
- 235000020971 citrus fruits Nutrition 0.000 claims description 3
- 238000004891 communication Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims description 3
- 229930182490 saponin Natural products 0.000 claims description 3
- 150000007949 saponins Chemical class 0.000 claims description 3
- 235000019160 vitamin B3 Nutrition 0.000 claims description 3
- 239000011708 vitamin B3 Substances 0.000 claims description 3
- 230000001568 sexual effect Effects 0.000 claims description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims 2
- 229910021529 ammonia Inorganic materials 0.000 claims 1
- 238000006114 decarboxylation reaction Methods 0.000 claims 1
- 230000006870 function Effects 0.000 abstract description 7
- 230000002708 enhancing effect Effects 0.000 abstract description 4
- 206010003210 Arteriosclerosis Diseases 0.000 abstract description 3
- 206010010774 Constipation Diseases 0.000 abstract description 3
- 206010020772 Hypertension Diseases 0.000 abstract description 3
- 208000007502 anemia Diseases 0.000 abstract description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract description 3
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 230000003908 liver function Effects 0.000 abstract description 3
- 230000002265 prevention Effects 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 208000010228 Erectile Dysfunction Diseases 0.000 abstract 1
- 240000008397 Ganoderma lucidum Species 0.000 abstract 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 abstract 1
- 206010027304 Menopausal symptoms Diseases 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 230000007177 brain activity Effects 0.000 abstract 1
- 201000001881 impotence Diseases 0.000 abstract 1
- LGZXYFMMLRYXLK-UHFFFAOYSA-N mercury(2+);sulfide Chemical compound [S-2].[Hg+2] LGZXYFMMLRYXLK-UHFFFAOYSA-N 0.000 abstract 1
- 235000013361 beverage Nutrition 0.000 description 10
- 230000000694 effects Effects 0.000 description 7
- 235000013305 food Nutrition 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003262 anti-osteoporosis Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 238000010025 steaming Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- XJLSEXAGTJCILF-RXMQYKEDSA-N (R)-nipecotic acid zwitterion Chemical compound OC(=O)[C@@H]1CCCNC1 XJLSEXAGTJCILF-RXMQYKEDSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 241001300479 Macroptilium Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- ILRCGYURZSFMEG-UHFFFAOYSA-N Salidroside Natural products OC1C(O)C(O)C(CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-UHFFFAOYSA-N 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940124277 aminobutyric acid Drugs 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000002102 hyperpolarization Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- ILRCGYURZSFMEG-RQICVUQASA-N salidroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-RQICVUQASA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000005062 synaptic transmission Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
An oral liquid containing gamma-aminobutyric acid is characterized by being prepared from components in percentage by weight as follows: 1.000% of a red ginseng concentrated solution, 0.050% of ganoderma lucidum powder, 1.000% of Chinese red dates, 0.100% of cassia bark, 0.100% of prepared rehmannia roots, 0.300% of Angelica sinensis, 12.000% of high fructose syrup, 0.165% of citric acid, 0.020% of vitamins, 0.030% of glycine, 0.050% of a gold extract, 0.5% of gamma-aminobutyric acid and 84.685% of distilled water. The oral liquid has the benefits that the oral liquid can relieve fatigue, promote brain activity, relieve anemia, prevent osteoporosis, relieve climacteric symptoms and erectile dysfunction, facilitate prevention of hypertension and diabetes, improve the liver function and enhance the antitumor activity, has functions of repairing damaged tissue, enhancing the immunity and reducing weight and has a relieving function on constipation and arteriosclerosis.
Description
Technical field
The invention belongs to technical field of beverage, a kind of oral liquid containing gamma-aminobutyric acid.
Background technology
γ-aminobutyric acid, English name: γ-aminobutyric acid (GABA), chemical name: 4-Aminobutanoicacid
, another name: γ-aminobutyric acid, aminobutyric acid, nipecotic acid.Molecular formula: C4H9NO2.Molecular weight: 103.1.It is distributed widely in dynamic planting
In object.Seed, rhizome and the tissue fluid of plant such as Macroptilium, ginseng genus, Chinese herbal medicine etc. all contains GABA.In animal body,
GABA almost exists only in nervous tissue, and the content in its mesencephalic tissue is about 0.1-0.6mg/ gram of tissue, and immunology is ground
Studying carefully and show, the region that its concentration is the highest is black substance in brain.GABA is to study the most deep a kind of important inhibition at present
Neurotransmitter, it participates in multiple metabolic activity, has the highest physiologically active, has neurotransmission, improves brain function, enhancing note
Recall, anxiety, treatment epilepsy, Control of asthma, regulation hormone secretion, prevent obesity, promote reproduction, activation Liver and kidney, improve nerve
Cellularity senile dementia, alleviate cerebral thrombosis, alleviate cerebral arteriosclerosis cause headache, alleviate the physiological functions such as tinnitus, extensively should
For fields such as food, medicine, cosmetics and feedstuffs.
China Ministry of Public Health approved GABA is new resource food, can be in milk product, soft drink, chocolate, flavoring agent, baking
Roasting food and Wine add application.Accordingly, as a kind of naturally occur food stage human body and animal are had multiple life
The material of reason function, has vast potential for future development rich in GABA product.
The effects such as beverage not only has quick and easy characteristic, and having more promotes the production of body fluid quenches one's thirst, functions of relieving summer heat, antithermic.China's beverage is near
Development in several years is swift and violent, but its inherent quality of the beverage products of prior art differs greatly, and some beverage bacterium colonies exceed standard, and some
Beverage has been also added with pigment, preservative, and its nutrition is difficult to absorb, and the active ingredient of its beverage can not get preferably playing,
And had a strong impact on the healthy of consumer.
Along with raising and the enhancing of health perception of people's living standard, traditional beverage can not meet people to life
The pursuit of quality, the beverage with health care is increasingly favored by people.
Summary of the invention
It is an object of the invention to provide a kind of amino acid whose oral liquid Han gamma, not only having promotes the production of body fluid quenches one's thirst, functions of relieving summer heat, antithermic
Effect, and its nutrition is more prone to absorb, and the active ingredient of beverage can significantly be obtained by, and is more beneficial for disappearing
The person's of expense is healthy.
For solving above-mentioned technical problem, the technical solution adopted in the present invention is: a kind of being administered orally containing gamma-aminobutyric acid
Liquid, is characterized in that the described each composition containing gamma-aminobutyric acid oral liquid and percentage by weight are: Radix Ginseng Rubra concentrated solution
1.000%, Ganoderma powder 0.050%, Fructus Jujubae 1.000%, Cortex cinnamomi japonici (Ramulus Cinnamomi) 0.100%, Radix Rehmanniae Preparata 0.100%, Radix Angelicae Sinensis 0.300%, high fructose syrup
12.000%, citric acid 0.165%, vitamin 0.020%, glycine 0.030%, gold extract 0.050%, gamma-aminobutyric acid
0.5%, distilled water 84.685%.
Described Radix Ginseng Rubra concentrated solution, using Korea S's Radix Ginseng Rubra or Radix Ginseng is raw material, and first water steams 10 hours, infusion the most again
24 hours, infusion temperature controlled 85 DEG C, obtains red ginseng extract, was then formed through ultraviolet disinfection, concentration by extracting solution, its soap
Salidroside content more than 75%, have QI invigorating, YIN nourishing, benefit blood, promote the production of body fluid, heart tonifying, stomach invigorating, the effect such as calmness.
Described Ganoderma powder, uses superfine powder or spore powder, and superfine powder is that Ganoderma sporophore is pulverized through superfine communication technique
After powder, spore powder be Ganoderma in the growth and maturity phase, the most small avette reproduction shot out of being hit by a bullet from Ganoderma lamella is thin
The seed of born of the same parents, i.e. Ganoderma.
Described high fructose syrup, for fructose and the mixture of glucose, the wherein content 91% of fructose.
Described citric acid, uses the natural lemon acid extracted from Fructus Citri Limoniae, Citrus, Fructus Ananadis comosi.
Described vitamin, uses vitamin A, vitamin B, vitamin C, vitamin D, vitamin E, vitamin K, dimension
The mixture of more than two kinds in raw element H, Citrin, vitamin PP, vitamin(e) M, vitamine T, vitamin U.
Described gold extract, for the mixture using nanotechnology to extract from gold, has protection human body protein
And destroy the effect of malignant cell.
Described gamma-aminobutyric acid, uses fermented by lactic acid bacteria to produce, through the catalytic action of glutamic acid decarboxylase organized enzyme, makes
Glutamic acid decarboxylase is gamma-aminobutyric acid, and the least concentration of glutamic acid is 8mmoL/L, produces gamma-aminobutyric acid without miscellaneous bacteria, food
By safety.
Fructus Jujubae, Cortex cinnamomi japonici (Ramulus Cinnamomi), Radix Rehmanniae Preparata, Radix Angelicae Sinensis are pulverized respectively, cross 800 mesh sieves, then, then with Radix Ginseng Rubra concentrated solution, Ganoderma powder,
High fructose syrup, citric acid, vitamin, glycine, gold extract, gamma-aminobutyric acid, distilled water load agitator tank together and stir
Mixing 6 hours, whipping temp controls at 30 DEG C, then subpackage.
The invention has the beneficial effects as follows that the oral liquid containing gamma-aminobutyric acid contains gamma-aminobutyric acid, cyton film can be made
Permeability increase, produce hyperpolarization, advantageously in the absorption of nutrient substance, so that the active ingredient of oral liquid of the present invention
Obtain bigger performance.
The present invention oral liquid containing gamma-aminobutyric acid contains the rare Chinese medicines such as Radix Ginseng Rubra concentrated solution, Ganoderma powder, has anti-
Tired, promote cerebral activity, alleviate anemia, pre-anti-osteoporosis, improve menopause syndrome, improve erection disturbance, have
It is beneficial to hypertension and the prevention of diabetes, improves liver function, enhancing active anticancer, there is the impaired tissue of reparation, increase immunity
Power and the function of fat-reducing, also have improvement effect to constipation, arteriosclerosis.
Detailed description of the invention:
Further illustrate the present invention below in conjunction with embodiment, but embodiment is only that the explanation present invention rather than carries out it
Limit.
Embodiment 1:
Needed for preparing 1000 grams of oral liquids containing gamma-aminobutyric acid, the weight of each composition is as follows: Radix Ginseng Rubra concentrated solution 10.00
Gram, Ganoderma powder 0.50 gram, 10.00 grams of Fructus Jujubae, 1.00 grams of Cortex cinnamomi japonici (Ramulus Cinnamomi), Radix Rehmanniae Preparata 1.00 grams, Radix Angelicae Sinensis 3.00 grams, high fructose syrup 120.00
Gram, citric acid 1.65 grams, vitamin 0.20 gram, glycine 0.30 gram, gold extract 0.50 gram, gamma-aminobutyric acid 5.00
Gram, distilled water 846.85 grams.
Described Radix Ginseng Rubra concentrated solution, using Korea S's Radix Ginseng Rubra is raw material, and first water steams 10 hours, and infusion 24 hours, endure the most again
Boiling temperature and control 85 DEG C, obtain red ginseng extract, then formed through ultraviolet disinfection, concentration by extracting solution, its saponin content exists
More than 75%.
Described Ganoderma powder, uses superfine powder, and superfine powder is Ganoderma sporophore powder after superfine communication technique is pulverized.
Described high fructose syrup, for fructose and the mixture of glucose, the wherein content 91% of fructose.
Described citric acid, uses the natural lemon acid extracted from Fructus Citri Limoniae.
Described vitamin, uses vitamin A, vitamin B, vitamin C, vitamin D, vitamin E, vitamin K, dimension
The mixture of raw element H.
Described gold extract, for the mixture using nanotechnology to extract from gold.
Described gamma-aminobutyric acid, uses fermented by lactic acid bacteria to produce, through the catalytic action of glutamic acid decarboxylase organized enzyme, makes
Glutamic acid decarboxylase is gamma-aminobutyric acid, and the least concentration of glutamic acid is 8mmoL/L.
The Fructus Jujubae of above-mentioned weight, Cortex cinnamomi japonici (Ramulus Cinnamomi), Radix Rehmanniae Preparata, Radix Angelicae Sinensis are pulverized respectively, cross 800 mesh sieves, then, then with above-mentioned weight
Radix Ginseng Rubra concentrated solution, Ganoderma powder, high fructose syrup, citric acid, vitamin, glycine, gold extract, gamma-aminobutyric acid, steaming
Distilled water loads agitator tank together and stirs 6 hours, and whipping temp controls at 30 DEG C, then subpackage.
Embodiment 2:
Needed for preparing 2000 grams of oral liquids containing gamma-aminobutyric acid, the weight of each composition is as follows: Radix Ginseng Rubra concentrated solution 20.00
Gram, Ganoderma powder 1.00 grams, 20.00 grams of Fructus Jujubae, 2.00 grams of Cortex cinnamomi japonici (Ramulus Cinnamomi), Radix Rehmanniae Preparata 2.00 grams, Radix Angelicae Sinensis 6.00 grams, high fructose syrup 240.00
Gram, citric acid 3.30 grams, vitamin 0.40 gram, glycine 0.60 gram, gold extract 1.00 grams, gamma-aminobutyric acid 10.00
Gram, distilled water 1693.70 grams.
Described Radix Ginseng Rubra concentrated solution, employing Radix Ginseng is raw material, and first water steams 10 hours, and infusion 24 hours, endure the most again
Boiling temperature and control 85 DEG C, obtain red ginseng extract, then formed through ultraviolet disinfection, concentration by extracting solution, its saponin content exists
More than 75%.
Described Ganoderma powder, uses spore powder, spore powder be Ganoderma in the growth and maturity phase, being hit by a bullet from Ganoderma lamella shoots out
The most small avette sexual cell, the i.e. seed of Ganoderma.
Described high fructose syrup, for fructose and the mixture of glucose, the wherein content 91% of fructose.
Described citric acid, uses the natural lemon acid extracted from Citrus.
Described vitamin, uses vitamin A, vitamin B, vitamin C, vitamin D, vitamin E, vitamin K, dimension
Raw element H, Citrin, vitamin PP, vitamin(e) M, vitamine T, the mixture of vitamin U.
Described gold extract, for the mixture using nanotechnology to extract from gold.
Described gamma-aminobutyric acid, uses fermented by lactic acid bacteria to produce, through the catalytic action of glutamic acid decarboxylase organized enzyme, makes
Glutamic acid decarboxylase is gamma-aminobutyric acid, and the least concentration of glutamic acid is 8mmoL/L.
The Fructus Jujubae of above-mentioned weight, Cortex cinnamomi japonici (Ramulus Cinnamomi), Radix Rehmanniae Preparata, Radix Angelicae Sinensis are pulverized respectively, cross 800 mesh sieves, then, then with above-mentioned weight
Radix Ginseng Rubra concentrated solution, Ganoderma powder, high fructose syrup, citric acid, vitamin, glycine, gold extract, gamma-aminobutyric acid, steaming
Distilled water loads agitator tank together, stirs 6 hours, and whipping temp controls at 30 DEG C, then subpackage.
The invention has the beneficial effects as follows that the oral liquid containing gamma-aminobutyric acid contains gamma-aminobutyric acid and Radix Ginseng Rubra concentrates
The rare Chinese medicine such as liquid, Ganoderma powder: there is resisting fatigue, promote cerebral activity, alleviation anemia, pre-anti-osteoporosis, improvement more
Term symptom, improve erection disturbance, be conducive to hypertension and the prevention of diabetes, improve liver function, strengthen active anticancer,
Have and repair impaired tissue, increase immunity and the function of fat-reducing, constipation, arteriosclerosis are also had improvement effect.
The present invention oral liquid containing gamma-aminobutyric acid suits the taste of both old and young, and is suitable for all groups, does not has toxic and side effects.
Claims (1)
1. the oral liquid containing gamma-aminobutyric acid, is characterized in that described respectively forming into containing gamma-aminobutyric acid oral liquid
Part and percentage by weight be: Radix Ginseng Rubra concentrated solution 1.000%, Ganoderma powder 0.050%, Fructus Jujubae 1.000%, Cortex cinnamomi japonici (Ramulus Cinnamomi) 0.100%, Radix Rehmanniae Preparata
0.100%, Radix Angelicae Sinensis 0.300%, high fructose syrup 12.000%, citric acid 0.165%, vitamin 0.020%, glycine 0.030%, gold
Extract 0.050%, gamma-aminobutyric acid 0.5%, distilled water 84.685%；
Described Radix Ginseng Rubra concentrated solution, using Korea S's Radix Ginseng Rubra or Radix Ginseng is raw material, and first water steams 10 hours, and infusion 24 is little the most again
Time, infusion temperature controls 85 DEG C, obtains red ginseng extract, is then formed through ultraviolet disinfection, concentration by extracting solution, and its Saponin contains
Amount is more than 75%；
Described Ganoderma powder, uses superfine powder or spore powder, and superfine powder is that Ganoderma sporophore is after superfine communication technique is pulverized
Powder, spore powder be Ganoderma in the growth and maturity phase, the most small avette sexual cell shot out of being hit by a bullet from Ganoderma lamella, i.e.
The seed of Ganoderma；
Described high fructose syrup, for fructose and the mixture of glucose, the wherein content 91% of fructose；
Described citric acid, uses the natural lemon acid extracted from Fructus Citri Limoniae, Citrus, Fructus Ananadis comosi；
Described vitamin, uses vitamin A, vitamin B, vitamin C, vitamin D, vitamin E, vitamin K, vitamin
The mixture of more than two kinds in H, Citrin, vitamin PP, vitamin(e) M, vitamine T, vitamin U；
Described gold extract, for the mixture using nanotechnology to extract from gold；
Described gamma-aminobutyric acid, uses fermented by lactic acid bacteria to produce, through the catalytic action of glutamic acid decarboxylase organized enzyme, makes paddy ammonia
Acid decarboxylation is gamma-aminobutyric acid, and the least concentration of glutamic acid is 8mmoL/L, and production gamma-aminobutyric acid, without miscellaneous bacteria, eats peace
Entirely.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610391411.7A CN106036314A (en) | 2016-06-06 | 2016-06-06 | Oral liquid containing gamma-aminobutyric acid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610391411.7A CN106036314A (en) | 2016-06-06 | 2016-06-06 | Oral liquid containing gamma-aminobutyric acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106036314A true CN106036314A (en) | 2016-10-26 |
Family
ID=57169813
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610391411.7A Pending CN106036314A (en) | 2016-06-06 | 2016-06-06 | Oral liquid containing gamma-aminobutyric acid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106036314A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113413395A (en) * | 2021-06-30 | 2021-09-21 | 江西普正制药股份有限公司 | Composition containing pinoresinol diglucoside and preparation method and application thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1543876A (en) * | 2003-11-19 | 2004-11-10 | 西安利君制药股份有限公司 | Novel monascin oral liquid and method for producing the same |
| CN101926459A (en) * | 2009-11-20 | 2010-12-29 | 张小夫 | Preparation for improving learning memory and preventing test anxiety and preparation method thereof |
| CN101990964A (en) * | 2010-11-26 | 2011-03-30 | 王一军 | Inflammation-diminishing heart-nourishing tea relieving gynecological inflammation and menopause manic depression |
| CN102423077A (en) * | 2011-11-28 | 2012-04-25 | 李忠义 | Diabetes functional beverage gamma balance liquid |
| CN102885303A (en) * | 2012-10-09 | 2013-01-23 | 西藏月王生物技术有限公司 | High-r-aminobutyric-acid-content highland-barley red yeast and preparation method thereof |
| CN105077477A (en) * | 2015-08-12 | 2015-11-25 | 北京晚安科技有限责任公司 | Sleeping-aid beverage |
-
2016
- 2016-06-06 CN CN201610391411.7A patent/CN106036314A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1543876A (en) * | 2003-11-19 | 2004-11-10 | 西安利君制药股份有限公司 | Novel monascin oral liquid and method for producing the same |
| CN101926459A (en) * | 2009-11-20 | 2010-12-29 | 张小夫 | Preparation for improving learning memory and preventing test anxiety and preparation method thereof |
| CN101990964A (en) * | 2010-11-26 | 2011-03-30 | 王一军 | Inflammation-diminishing heart-nourishing tea relieving gynecological inflammation and menopause manic depression |
| CN102423077A (en) * | 2011-11-28 | 2012-04-25 | 李忠义 | Diabetes functional beverage gamma balance liquid |
| CN102885303A (en) * | 2012-10-09 | 2013-01-23 | 西藏月王生物技术有限公司 | High-r-aminobutyric-acid-content highland-barley red yeast and preparation method thereof |
| CN105077477A (en) * | 2015-08-12 | 2015-11-25 | 北京晚安科技有限责任公司 | Sleeping-aid beverage |
Non-Patent Citations (1)
| Title |
|---|
| 包祖晓: "《焦虑症诊治心悟》", 30 April 2015, 人民军医出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113413395A (en) * | 2021-06-30 | 2021-09-21 | 江西普正制药股份有限公司 | Composition containing pinoresinol diglucoside and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102106580B (en) | Sobering-up and liver-protecting health beverage | |
| CN101703221B (en) | Food supplement for incretion regulation, blood enrichment, skin maintenance, hairdressing and speckle removal and preparation method thereof | |
| CN103099089A (en) | Health-care product for reducing blood sugar and blood pressure, relaxing bowels, losing weight, resisting fatigue and improving sexual function and production technology thereof | |
| CN109316517A (en) | A kind of preparation method and application of fresh ginseng cream | |
| CN101971894A (en) | Compound burdock health protection tea | |
| CN103504444A (en) | Method for preparing mythic fungus and dictyophora phalloidea solid beverage | |
| CN103859379A (en) | Formula and preparation method of life cultivation and health preservation food helpful for improving memory | |
| CN104922550A (en) | Traditional Chinese medicine combination and application thereof | |
| CN105876548A (en) | Fruit and vegetable drink with maca and radix ginseng, method for preparing fruit and vegetable drink and application thereof | |
| CN109316528B (en) | Medicine for treating male erectile dysfunction and preparation method thereof | |
| CN103330021B (en) | Health-preserving tea | |
| CN107853517B (en) | Traditional Chinese medicine beverage capable of refreshing and resisting fatigue and preparation method thereof | |
| CN103315086B (en) | Health-preserving tea | |
| CN101525569A (en) | Body-building anti-aging health-care wine | |
| CN101181541A (en) | Toxin-expelling body-building medicine liqueur | |
| CN104109609A (en) | Glutinous rice wine buckwheat juice beverage and preparation method thereof | |
| CN105454944A (en) | Ginseng drink and preparing method | |
| CN103027139A (en) | Health tea suitable for use in all seasons | |
| CN106923115A (en) | Plant beverage containing west safflower and its preparation method and application | |
| CN102604802B (en) | Preparation method of originally ecological bamboo-germanium nutritional wine | |
| CN105054180A (en) | Health-care rose beverage for regulating blood lipid | |
| CN102204613A (en) | Pressure stabilizing and blood activating Chinese medicinal health locust bean tea | |
| CN104186657B (en) | A kind of bighead atractylodes rhizome milk vinegar green-tea health-care beverage | |
| CN102613648B (en) | Preparation method of original ecological bamboo germanium nutrient solution | |
| CN106036314A (en) | Oral liquid containing gamma-aminobutyric acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20161026 |
|
| WD01 | Invention patent application deemed withdrawn after publication |